<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03704415</url>
  </required_header>
  <id_info>
    <org_study_id>AirGOs Operative</org_study_id>
    <nct_id>NCT03704415</nct_id>
  </id_info>
  <brief_title>Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)</brief_title>
  <official_title>Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized study compares operative techniques in chronic rhinosinusitis with polyposis
      (CRSwNP) surgery. It aims to evaluate outcomes in asthma and CRSwNP, safety and costs. The
      investigators want to see if patients with certain clinical and/or genetic predispositions
      will benefit from extended surgery. They also aim to find biomarkers for detection and
      management models for of severe airway inflammation and to further develop markers for
      progressive disease forms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Please see study protocol
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 23, 2018</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sino-nasal outcome test (SNOT-22)</measure>
    <time_frame>Baseline, Post-intervention every 3 months during 2 years</time_frame>
    <description>Change from baseline in patient symptoms as measured by the Sino-Nasal Outcomes Test (SNOT-22) survey. Scores are measured from 0-5 in a 22 item validated survey. Total scores range from 0-110 with higher scores indicating greater burden of sinonasal symptoms.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">174</enrollment>
  <condition>Sinusitis, Chronic</condition>
  <condition>Asthma</condition>
  <condition>Nasal Polyps</condition>
  <condition>Aspirin Sensitivity</condition>
  <arm_group>
    <arm_group_label>Extended</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Extended sinus surgery including all sinuses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Limited</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Limited sinus surgery with partial ethmoidectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extended endoscopic sinus surgery</intervention_name>
    <description>ESS of all sinuses</description>
    <arm_group_label>Extended</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Limited endoscopic sinus surgery</intervention_name>
    <description>Partial ethmoidectomy</description>
    <arm_group_label>Limited</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient not responding to conservative treatment of 3 months of nasal steroid drops

          -  Nasal polyp score ≥ 4/8

          -  SNOT-22 ≥ 30

          -  Lund-Mackay CT score ≥ 14

          -  One previous endoscopic sinus surgery or at least one peroral corticosteroid course or
             at least 3 courses of antibiotics within 2 years

        Exclusion Criteria:

          -  Age &lt;18 years, age &gt; 65 years

          -  Complication of CRS (f.e. mucocele, invasive fungal rhinosinusitis)

          -  Other diagnosis than CRSwNP (inverted papilloma, antrochoanal polyp etc.)

          -  Previous external sinus surgery or Draf 3 procedure (or indication for external
             approaches or Draf 3

          -  Bleeding diathesis

          -  Pregnancy/ breastfeeding

          -  Cystic fibrosis

          -  Primary ciliary dyskinesia (PCD)

          -  Sarcoidosis

          -  Granulomatosis with polyangitis (GPA)

          -  Eosinophilic granulomatosis with polyangitis (EGPA)

          -  Immunosupression (diagnosed Spesific Antibody Deficiency (SAD), common variable
             immunodeficiency (CVI), HIV or use of biologicals/immunosuppressive medication)

          -  Immunotherapy

          -  Daily use of systemic corticosteroids

          -  Communication problems (f.e. neurological/psychiatric disease, language skills)

          -  Unlikely to comply

          -  Other severe disease

          -  Inability to be operated.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paula Virkkula, Docent</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paula Virkkula, Dosent</last_name>
    <phone>+358-50-4279143</phone>
    <email>paula.virkkula@hus.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Otorhinolaryngology, Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00380</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Virkkula, MD, PhD</last_name>
      <phone>+358-504279143</phone>
      <email>paula.virkkula@hus.fi</email>
    </contact>
    <contact_backup>
      <last_name>Sari Hammarén-Malmi, MD, PhD</last_name>
      <phone>+358-0-4711</phone>
      <email>sari.hammaren-malmi@hus.fi</email>
    </contact_backup>
    <investigator>
      <last_name>Virkkula</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hammarén-Malmi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laulajainen-Hongisto</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hafrén</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kauppi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lilja</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vento</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wikstén</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johanna Sahlman, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sietze Reitsma, MD</last_name>
      <phone>+31642135872</phone>
      <email>s.reitsma@amsterdamumc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Wytske Fokkens, MD, PhD</last_name>
      <phone>+31634150093</phone>
      <email>w.j.fokkens@amsterdamumc.nl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 8, 2018</study_first_submitted>
  <study_first_submitted_qc>October 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2018</study_first_posted>
  <last_update_submitted>March 1, 2020</last_update_submitted>
  <last_update_submitted_qc>March 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Paula Virkkula</investigator_full_name>
    <investigator_title>Chief Physician in Rhinology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Nasal Polyps</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures and appendices) can be shared.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Beginning 3 months and ending 3 years after article publication.</ipd_time_frame>
    <ipd_access_criteria>Researchers who provide a methodologically sound proposal.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 23, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/15/NCT03704415/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

